Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia. Saultier P, Ninove L, Szepetowski S, Veneziano M, et al. Br J Haematol 2022;196:e1-e3.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saultier P, Ninove L, Szepetowski S, Veneziano M, et al. Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia. Br J Haematol 2022;196:e1-e3.
PMID: 34337739